Prostate cancer is the most commonly diagnosed malignancy and is the third leading cause of cancer death among men in developed countries 1 . In the United States alone, an estimated 242,000 men will be diagnosed with prostate cancer in 2012 and 28,000 will die from their disease 2 . Despite its high incidence and mortality, few risk factors have so far been identified for prostate cancer beyond increasing age, a family history of prostate cancer 3 , certain genetic polymorphisms or mutations (such as single nucleotide polymorphisms (SNPs) in the 8q24 and 17q12 chromosomal regions 4 ), living in a Western nation and African descent. Being of Asian descent is protective for prostate cancer. Migration studies also clearly show that men who migrate from countries with low prostate cancer mortality, such as Japan, assume a higher rate when they move to Western countries with a higher mortality 3 . This observation, together with increasing prostate cancer mortality rates over time, particularly in countries with traditionally low rates 5 , strongly suggests that environmental or lifestyle factors contribute to prostate carcinogenesis. However, despite this compelling ecological evidence, as well as decades of observational research and clinical trials of the most promising suspected dietary protective factors (such as selenium and vitamin E 6, 7 ), no conclusive modifiable environmental or lifestyle risk factors have yet been identified.
We propose that one possible reason for this dearth of modifiable risk factors is the predominant focus of prostate cancer research on mid-life to later-life exposures, long after the prostate has developed, whereas earlier-life exposures, such as those that occur during childhood and adolescence when the prostate is still maturing, may be as, or more, important for prostate cancer risk. In this Opinion article, we summarize the rationale for, and the challenges to, studying these exposures, as well as results from the fairly small number of epidemiological Nature Reviews | Cancer studies of earlier-life exposures (early life is defined in this article as from infancy to the age of 30 years). Furthermore, we present our vision for how future studies might be carried out to maximize insight into the role of early-life exposures in prostate cancer risk.
Early-life prostate changes Aside from gestation, early life is the only other time during the lifespan when the immature prostate grows and develops. Following birth, the prostate enters an infantile resting state that is characterized by continued prostate duct formation, but little change in size 8 . With the onset of puberty, however, the prostate begins to grow and develop more rapidly and this continues until the end of puberty when it reaches approximately adult size and morphology 8, 9 (FIG. 1) .
Figure 1 | Prostate development and pathology across the life span.
During childhood, although prostate ducts continue to develop, the immature prostate changes little in size. Part a is a histological image of an immature prostate from a 3-year-old boy. With the onset of puberty, the prostate begins to grow and develop more rapidly, and this continues until the end of puberty when it reaches approximately adult size and morphology. Part b is a histological image of a prostate from an adolescent boy. By 19-29 years of age, evidence of pre-neoplastic and neoplastic prostate alterations can be observed. Proliferative and/or atrophic lesions similar to those proposed to be early prostate cancer precursor lesions have been observed in more than 50% of men examined. Part c is a histological image of a proliferative, atrophic lesion accompanied by inflammation. Foci of established precursor lesions, such as high-grade prostatic intraepithelial neoplasia (HGPIN), and microscopic, histological prostate cancer have also been observed in a small proportion of men (0.0-7.1% of men for HGPIN and 0.0-3.6% of men for histological prostate cancer). In addition to histological changes, differences in levels of prostate-specific antigen (PSA) -an intraluminal protein that leaks into circulation when the prostate epithelium is disrupted, such as by inflammation (a possible risk factor for prostate cancer) and by prostate cancer itself -have been observed in young men by race. That is, higher PSA levels have been observed in young AfricanAmerican men than in Caucasian-American men in their twenties.
By 30-39 years of age (part d), evidence of pre-neoplastic and neoplastic changes is even more striking. HGPIN and/or histological prostate cancer have been found in a greater proportion of men examined (0.0-11.8% for HGPIN and 0.0-28.9% for histological prostate cancer), racial disparities in PSA persist, differences in PSA translate into future prostate cancer risk (that is, prostate cancer diagnosis several decades later) and differences in prostate cancer incidence begin to appear by race. The image in part d shows a histological image of an HGPIN lesion. In men of 40-49 years of age (part e) HGPIN and/or histological prostate cancer have been found in a greater proportion of men examined (5.3-35.7% for HGPIN and 0.0-34.0% for histological prostate cancer), racial disparities in PSA continue to persist, PSA levels are consistently predictive of future prostate cancer risk and mortality, and racial disparities in prostate cancer mortality (rather than only incidence) begin to appear. The image in part e shows a histological image of a prostate cancer lesion discovered at autopsy. Image in part a is reproduced, with permission, from REF. During these early developmental stages, and possibly immediately afterwards, the prostate may be especially susceptible to endogenous and exogenous carcinogenic exposures [10] [11] [12] , as has been demonstrated for other maturing organs, such as the breast 13 . Women exposed to the Hiroshima and Nagasaki atomic bombs in Japan in the first two decades of life were found to have a higher risk of breast cancer than those exposed later in life, indicating a greater susceptibility to breast carcinogens earlier in life 14 . Unfortunately, whether because of an overall lack of association with ionizing radiation 14 , or because of the sparseness of the data for adolescent and young male atomic bomb survivors 15 , these studies have been less informative for prostate cancer risk. However, data from mathematical models do suggest that the initiating genomic alteration for prostate cancer may occur as early as puberty (that is, 14 years of age) 16 .
Although not necessarily specific to puberty, several additional lines of evidence point to the early development of preneoplastic and neoplastic prostate alterations. In a study of men of 19-29 years of age, proliferative and/or atrophic lesions were observed in more than 50% of the prostate specimens that were examined 17 . These lesions are increasingly believed to serve as early prostate cancer precursor lesions or as markers of an environment that is conducive to prostate cancer development 18 . Several other studies also observed foci of established precursor lesions, high-grade prostatic intraepithelial neoplasia (HGPIN) and microscopic prostate cancer lesions in a small proportion of men in their twenties (HGPIN: 0.0-7.1%; prostate cancer: 0.0-3.6%) [19] [20] [21] [22] [23] [24] . These microscopic, autopsy-detected lesions are frequently referred to as histological or latent prostate cancer (as opposed to clinically manifest cancer) because their future clinical potential is generally unknown, even when detected in older men 25, 26 . Although early-adulthood autopsy studies had too few participants to examine differences in histological lesion prevalence by race, larger studies of other early-life prostate changes (for example, levels of prostate-specific antigen (PSA)) observed expected racial differences: that is, higher serum PSA values for young AfricanAmerican men than for Caucasian-American men in their twenties, particularly at the upper end of the distribution curve of PSA levels 27, 28 . PSA is an intraluminal protein that leaks into the circulation when the prostate epithelium is disrupted, such as by inflammation 29 (a possible risk factor for prostate cancer 18 ) and by prostate cancer itself 29 . Therefore, one possible interpretation of these findings is that changes in the prostate environment that may be related to both future prostate cancer risk 28, 37 and racial disparities in risk occur early in life.
By the time men reach their thirties, evidence of pre-neoplastic and neoplastic prostate alterations is even more striking. HGPIN and/or histological prostate cancer are found in a greater proportion of men examined (HGPIN: 0.0-11.8%; prostate cancer: 0.0-28.9%) [19] [20] [21] [22] [23] [24] [30] [31] [32] [33] [34] [35] , racial disparities in PSA persist 27, 28, 36 , differences in PSA translate into future prostate cancer risk (that is, prostate cancer diagnosis several decades later) 28, 37 and, most importantly, differences in prostate cancer incidence begin to appear by race 38 . Finally, by the time men reach their forties, PSA levels are consistently predictive of future prostate cancer risk and mortality 37, [39] [40] [41] [42] [43] [44] [45] , and racial disparities in prostate cancer mortality (rather than only incidence) become apparent 38 (FIG. 1) . Clearly, the factors that are responsible for these changes -whether genomic, lifestyle related, or both -must have occurred decades earlier.
Barriers to early-life research Despite these compelling reasons for studying early-life exposures, most epidemiological research has focused on mid-life to later-life men for two major reasons. The first reason relates to observations made in the 1970s and 1980s of unexpectedly smaller differences in the prevalence of histological prostate cancer in middle-aged and older-aged men of differing races (for example, African-American men versus Caucasian-American men) and nationalities (for example, Japanese nationals versus Japanese-American men) relative to the large racial and geographic differences in clinical prostate cancer incidence and mortality [46] [47] [48] . This led to the hypothesis that factors that initiate prostate cancer are common to all men, whereas factors that promote prostate cancer vary by race and nationality 49 . As prostate cancer promotion probably occurs later in life, this hypothesis focused research into modifiable risk factors on mid-life to later-life men.
However, other histological observations have contradicted this hypothesis. In more recent studies of men from low-prostatecancer-risk regions, such as Spain, China and South-East Asia, the expected lower prevalence of histological prostate cancer has been observed compared with in higherrisk populations 22, 23, 32, 33, 49 . Additionally, when histological tumour size and grade are considered, both of which inform future clinical potential, considerably larger differences in the prevalence of histological prostate cancer have been observed by race and nationality in both original and more recent studies 33, 46, 47, 50 . Therefore, rather than occurring randomly in all men, initiation or early promotion of histological prostate cancer -and more importantly, prostate cancer with greater future potential for progression to clinically relevant disease -may vary by race-and nationality-associated factors, and thus may be modifiable.
The second reason for the dearth of research on early-life modifiable exposures is feasibility. Prostate cancer incidence and mortality are low in men of <50 years of age and only begin to rise when men reach their fifties and sixties (the median age at diagnosis is 67 years and at death from prostate cancer is 80 years in the United States 38 ). Therefore, although the time between early life and prostate cancer diagnosis or death may be as short as two decades, it may also be as long as seven decades. This long time span makes cohort studies of directly observed early-life exposures and prostate cancer diagnosis or death essentially impractical, except in unique situations, such as when records from studies of children or adolescents that were conducted several decades ago can be linked to currently available cancer registry data [51] [52] [53] [54] [55] . Therefore, most other investigators have instead relied on recall from older-aged men, raising concerns about the validity of decades-long recall in elderly participants.
Summary of early-life studies
Migration. Natural experiments, such as exposure to ionizing radiation (as described above for atomic bomb survivors) and migration, offer insight into the window of aetiological relevance for cancer development. For example, comparisons of cancer risk between generations of migrants (that is, first-generation migrants versus second or later generations), as well as those who move at different times during their lives (that is, those who move earlier in life versus later in life) can point to ages of increased cancer susceptibility. For prostate cancer, although results from studies comparing migrant generations have tended to be conflicting [56] [57] [58] [59] [60] , most [61] [62] [63] [64] [65] [66] , but not all 67, 68 , studies of age at migration -or its complement, duration of residence -have observed increased prostate cancer risk or mortality with younger age changes in the prostate environment … occur early in life. at migration to Western countries. Although one possible interpretation of these findings is that men who migrate at earlier ages may acculturate (that is, assimilate culturally) to a greater degree, leading to a greater likelihood of prostate cancer screening and the detection of occult prostate cancer, another possible interpretation is that age at initial exposure to elements of a higher-risk environ ment or lifestyle may be important for prostate cancer risk and mortality.
Height. In addition to age at migration, another marker that may inform the window of aetiological relevance for prostate cancer risk is height. This measure is believed to be determined by levels of early-life growth factors, such as insulin-like growth factor 1 (IGF1), which can be influenced by both genetics and early-life modifiable exposures, such as childhood nutrition and infection burden, depending on levels of environmental adversity 69 . Although the precise determinants of height are not known, this measure is frequently used as a marker of cumulative early-life exposures because each of these mechanisms must function before attainment of adult height. Height is also an attractive marker from an epidemiological perspective because, contrary to other early-life exposures that must be recalled from adulthood, height can be easily measured in adulthood or reported with excellent validity 70 . In a recent meta-analysis of height and prostate cancer 71 , the results of 39 studies were combined and a positive association between height and prostate cancer risk (that is, taller men had a greater risk of prostate cancer than shorter men) was estimated; pooled rate ratio (or relative risk (RR) = 1.05; 95% confidence interval (CI) = 1.02-1.09 for each 10 cm increase in height (FIG. 2) ). This association was stronger for advanced prostate cancer (RR = 1.09; 95% CI = 0.99-1.21) and for cohort studies (RR = 1.09; 95% CI = 1.08-1.11), which tended to be conducted before the widespread implementation of prostate cancer screening by PSA levels when a large proportion of detected cancers presented clinically 71 . Therefore, these results suggest that exposures captured by height may be particularly important for the risk of clinically relevant disease. Although these findings cannot point conclusively towards early life as a crucial period for prostate cancer susceptibility, as they may also be explained by later-life correlates of height not controlled for in the aforementioned studies (for example, later-life influence of genetic determinants of height, although no overlap between SNPs for height and prostate cancer have yet On the basis of the results of 39 epidemiological studies, an overall positive association between height and prostate cancer risk (that is, taller men had a greater risk of prostate cancer than shorter men, pooled rate ratio or relative risk (RR) = 1.05; 95% confidence interval (CI) = 1.02-1.09 for each 10 cm increase in height) was estimated 71 . This association was stronger for cohort studies (RR = 1.09; 95% CI = 1.08-1.11) than for case-control studies (RR = 1.00; 95% CI = 0.93-1.07) and for advanced prostate cancer (RR = 1.09; 95% CI = 0.99-1.21) than for localized prostate cancer (RR = 1.06; 95% CI = 1.00-1.12). As cohort studies were more likely to have been conducted before the widespread implementation of prostate cancer screening by prostate-specific antigen levels, when a large proportion of detected cancers presented clinically, both of these findings suggest that height may be important for the risk of clinically relevant disease 71 . For each individual study, the number of prostate cancer cases (n) is shown, and the total number of men (cohort studies) or number of controls (case-control studies) (N) is shown. All pooled RRs were calculated using maximally adjusted RRs and random effects methodology. The position of each blue box indicates the magnitude of the RR, and the size of each box reflects the associated sample size. , the estimated linear association between early-adulthood BMI and prostate cancer pooled relative risk is 1.06 (95% confidence interval = 0.99-1.14) (line a). This may reflect the combination of two distinct associations: a positive association between increasing lean muscle mass as a marker of greater early-life androgen levels and prostate cancer (line b); and a protective association between increasing fat mass as a marker of delayed puberty and lower early-life androgen levels (or higher oestrogen levels) and prostate cancer (line c) 95 . The differentiation of adipose young men from non-adipose young men in future studies may elucidate these two hypothesized associations.
been detected 4, 72 ), these findings still provide support for a role of early-life exposures in prostate carcinogenesis.
Sex hormones.
On the basis of their role in normal prostate growth, development and maintenance, as well as the observed regression of advanced prostate cancer following testosterone suppression, androgens are strongly believed to contribute to prostate cancer development 3 . However, results from the large number of epidemio logical studies of mid-life to later-life circulating levels of androgens and prostate cancer risk have mostly been null to date 73 . To our knowledge, only one study has investigated hormone levels earlier in life (median age = 34 years; range: 20-55 years) 74 and closer in time to early adulthood when androgen levels reach their peak 75, 76 . Although this study observed no association between levels of individual hormones (including testosterone) and prostate cancer risk, it did observe positive associations for ratios of testosterone to oestradiol levels among Caucasian-American participants but not among African-American participants 74 .
Owing to the long time span between early life and prostate cancer diagnosis or death, most other studies have focused on recalled markers of early-life androgen levels, such as severe acne development 77 , frequency of early-life ejaculatory activity [78] [79] [80] and early-life lean muscle mass 81 . With respect to severe acne development, results from the handful of studies that have been conducted to date have been conflicting 54, [82] [83] [84] . By contrast, those from the small number of studies of early-life ejaculatory activity (which includes sexual intercourse, but may be more likely to capture masturbation and nocturnal emission) have tended to be null to protective (that is, men with higher frequencies of ejaculation had a similar or lower risk of prostate cancer than men with lower frequencies) [85] [86] [87] [88] . However, it is possible that ejaculation frequency may be a better marker of frequency of prostate duct clearance than of hormone levels, and prostate duct clearance has been proposed to protect against prostate cancer by reducing the contact time of accumulated carcinogens with prostate epithelial cells 89 . Finally, only two studies have investigated early-life lean muscle mass (calculated from weight and height rather than by more sophisticated methods) in relation to prostate cancer, and they had conflicting findings 82, 90 . The few studies of relative body size in peri-puberty [91] [92] [93] or puberty 12, 94 , and the larger number of studies of body mass index (BMI) in early adulthood (defined as from 18 years to 30 years) 63, 91, [95] [96] [97] are more difficult to interpret because they might have captured several different factors. These include earlylife lean muscle mass (which is related to greater androgen levels) 81 , early-life adiposity (which has been proposed to delay puberty in boys [98] [99] [100] and to lower pubertal androgen levels) 100 , or a combination of both 95 .
Robinson and colleagues 95 commented on this possibility in their recent meta-analysis of 16 studies of early-adulthood BMI and prostate cancer, in which they estimated a non-significant positive association for BMI (pooled RR = 1.06; 95% CI = 0.99-1.14 for each 5-unit increase in BMI). These authors noted that their estimated linear association between early-adulthood BMI and prostate cancer might, in fact, have combined two distinct associations: a positive association between early-adulthood BMI as a marker of lean mass in the lower, non-obese range of BMI; and a null or protective association between early-adulthood BMI as a marker of fat mass in the higher, obese range of BMI 95 (FIG. 3) . Indeed, protective associations or associations suggestive of a protective effect were observed for greater early-life adiposity with advanced prostate cancer risk in two American studies that had sufficient numbers of overweight or obese boys and young men to address this question 98, 100 . Therefore, it is possible that stronger positive associations may be observed between BMI as a marker of lean mass and prostate cancer in future studies that distinguish adipose young men from non-adipose young men. Although the promotion of lower early-life lean mass and higher fat mass is not a viable prostate cancer prevention strategy, further study of this reasonably well-recalled early-life exposure (correlation = 0.80-0.93 for validity of recall in middle-aged and older-aged men) 70, [101] [102] [103] is still important for its insight into timing and mechanisms of prostate cancer development, as these might lead to chemoprevention opportunities (that is, drugs targeted to identified molecular pathways).
Timing of puberty.
In addition to levels of hormones, the length of time that the prostate is exposed to high levels of androgens may also be important for cancer risk. For example, earlier age at onset of puberty increases the risk of breast cancer in women 13 , presumably by extending the length of time that breast epithelial cells are exposed to high levels of cyclical sex steroid hormones. By a similar reasoning, earlier age at onset of puberty may also increase the risk of prostate cancer in men 82, 92 . However, in contrast to women, for whom age at onset of puberty can be ascertained by a single measure (that is, menarche) with reasonable accuracy of recall 104 , no single measure exists for men. Furthermore, for the multiple measures that do exist (for example, age at first . Although future research into this biologically plausible hypothesis is certainly warranted, better methods for ascertaining age at onset of puberty in men are needed. It should also be recognized that, as for early-adulthood BMI, the value of further study is limited to insight into the timing and mechanisms of prostate cancer development and possible chemoprevention strategies. Altering pubertal timing -for example, through early-life obesity -is not a viable prostate cancer prevention strategy.
Sexual activity and infections. Early-life sexual activity is also closely related to androgen levels and timing of puberty. However, as it may be more likely to capture the likelihood and timing of exposure to sexually transmitted and transmissible infectious agents (FIG. 4) , which have been proposed to increase prostate cancer risk through inflammatory and oncogenic mechanisms 111 , we are considering it separately. Additionally, in contrast to most previously discussed potential early-life risk factors, sexual activity and exposure to sexually transmissible agents are modifiable and thus any conclusive findings can be translated into prevention strategies. In their metaanalysis of sexual behaviour and prostate cancer, Dennis and Dawson 112 pooled the results of several case-control studies of sexually related factors and prostate cancer, and estimated a positive association for age at first sexual intercourse (pooled odds ratio (OR) = 1.08; 95% CI = 1.02-1.15 for each 5-year decrease in age at first sexual intercourse based on 12 studies) and a nonsignificant, positive association for frequency of early-life sexual intercourse (OR = 1.14; 95% CI = 0.98-1.31 for three versus less than one time per week based on three studies). For circumcision, which may reduce the risk of acquiring sexually transmitted or transmissible infections, such as HIV infection 113 , protective associations or associations suggestive of a protective effect were also observed in several, but not all 11, 19, 114, 115 , case-control studies of circumcision and prostate cancer [116] [117] [118] , as well as in studies comparing prostate cancer prevalence and incidence by religion as a marker of circumcision status 119, 120 . Thus, these findings provide support for a role of early-life exposure to sexually transmissible infections in prostate carcinogenesis.
In contrast to these findings, those for recalled history of well-known, frequently symptomatic sexually transmitted infections (STIs) -such as gonorrhea, which is commonly acquired in adolescence and Bacteria were cultured from urethral swabs of 16 non-sexually active and 42 sexually active American adolescent boys (mean age = 16.0 years and 16.8 years, respectively). Sexually active boys had a greater mean total number of bacterial isolates than non-sexually active boys, including significant (P ≤0.05) greater mean numbers of aerobic Gram-negative rod (GNR) isolates and anaerobic Gram-positive cocci (GPC) isolates, and a non-significant greater mean number of anaerobic Gram-negative rod isolates. These findings suggest that sexual activity exposes the urethra to a wide range of new bacterial species 128 . GNC, Gram-negative cocci; GPR, Gram-positive rod; NA, not applicable. 
Glossary

Case-control studies
Epidemiological studies that compare two groups of individuals: those who have the condition under study (the cases) and those without the condition (the controls). A link between the suspected risk factor and the disease is suggested when the frequency of that risk factor is significantly different between cases and controls.
Cohort studies
Epidemiological studies of people who are divided into those who have or have not been exposed to a suspected risk factor and who are subsequently observed over time for the development of the disease of interest. A link between the suspected risk factor and the disease is indicated when the exposed and unexposed participants have a significantly different frequency of future development of the disease.
Confounding factors
Variables (also known as confounders) that are associated with both an exposure and a disease outcome such that they distort or mask the true effect of exposure in an epidemiological study. For example, alcohol consumption may seem to increase the risk of lung cancer because of confounding by cigarette smoking, a variable that is associated with, but not caused by, alcohol consumption and that is associated with an increased risk of lung cancer.
Correlates
Variables that are related statistically, but not necessarily causally, to another variable. For example, cigarette smoking is a correlate of alcohol consumption.
Ecological evidence
Derived from studies in which groups of people rather than individuals are analysed. Susceptible to ecologic fallacy, whereby the relation observed between variables on a population level may not reflect the relation between variables on an individual level.
Exposures
Variables the causal effects of which are to be estimated. For example, environmental and lifestyle factors, socioeconomic and working conditions, medical treatments and genetic traits.
Markers
Variables (such as height) that may be related causally or non-causally to another variable of interest (such as levels of early-life growth factors). Can be useful for estimating the variable of interest if that variable cannot be measured or assessed directly. The number of analyses carried out for each suspected dietary risk factor was obtained by retrieving the latest meta-analysis or review article for each dietary factor [164] [165] [166] [167] [168] and then adding the number of analyses published between the date of the respective meta-analysis and October 2012. Additional analyses were obtained by searching the PubMed database (see Further information) with the search terms selenium; dairy; milk; calcium; tomato; lycopene; meat; α-linolenic acid; fatty acid; and prostate cancer.
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early-adulthood 121 -have been less conclusive. Although results for case-control studies have tended to be positive (pooled OR = 1.4; 95% CI = 1.2-1.7 based on 17 studies 112 ), those for cohort studies were mostly null 111 . As case-control studies require participants to recall exposures after prostate cancer diagnosis, whereas cohort studies ascertain exposures before diagnosis, these discrepancies raise the possibility of recall bias (that is, cases may have been more likely to report their STI history truthfully than controls). This concern is also relevant for studies of age at first sexual intercourse and frequency of early-life sexual activity. However, as protective findings were observed for circumcision status, which should be less influenced by recall bias, as well as for early-life ejaculation frequency, which should be subject to the same recall influences as early-life sexual activity, recall bias may be less of a concern. Positive associations are also beginning to be observed for additional less well-studied and frequently asymptomatic STIs, such as Trichomonas vaginalis 111 and mycoplasma infections [122] [123] [124] . Finally, although not typically investigated in relation to solid tumour risk, at least four studies have examined childhood infections and infection-related procedures in relation to prostate cancer 83, 94, 106, 125 . These include studies of rheumatic fever, tonsillectomy, appendectomy, measles, mumps and several other infections. Although findings for most of these infections and procedures were null, positive associations were observed for rheumatic fever 106, 125 and tonsillectomy 125 , both of which are, interestingly, related to Streptococcus pyogenes. Rheumatic fever is a now rare complication of S. pyogenes infection and tonsillectomy is frequently carried out for S. pyogenes tonsillitis. These unusual findings are difficult to explain but perhaps, similar to one mechanism proposed for severe acne and prostate cancer 126 , they imply altered susceptibility or immune sensitivity to infection, which could be relevant for prostate cancer in the case of prostate infection. Although Streptococcus species are not typically considered to be prostate pathogens, they have been detected in prostate specimens 127 , as well as in the urethra following the onset of sexual activity 128 , suggesting that they may be transmitted by sexual activity and thus could contribute to a sexually transmissible aetiology of prostate cancer. Alternatively, these findings may point to a more general role for immune sensitivity to infection or other prostatic stimuli in prostate carcinogenesis.
Physical activity. As alluded to above for sexual activity and STIs, an attractive feature of studying exposures such as early-life physical activity is the ability to intervene with these exposures if they are found to be associated with later prostate cancer risk. Unfortunately, however, only limited 129 evidence of an association has been observed between physical activity (typically later-life or lifetime activity) and prostate cancer in the fairly large number of epidemiological studies conducted to date. Mostly null associations or, occasionally, associations suggestive of a protective effect have also been observed in the smaller number of studies of early-life physical activity when activity was recalled approximately 4-6 decades later in life 12, 63, 94, [130] [131] [132] [133] [134] [135] [136] [137] [138] . Although positive findings were observed for major varsity athletes 51 and students who reported ≥5 hours per week of physical activity 52 in two studies of US college students, these findings may potentially have been complicated by confounding factors that are associated with both high levels of physical activity and possibly increased prostate cancer risk, such as earlier age at growth spurt, greater meat consumption or greater body build, although adjustment for height and/or weight did not change these findings 51, 52 . Thus, overall, these findings do not support a protective role for early-life physical activity in prostate cancer development.
Despite these mostly null findings, earlylife physical activity may warrant further study for two reasons: it is modifiable and has benefits beyond prostate cancer; and slightly stronger protective associations were observed for other aspects of physical activity measured with less recall time and greater reproducibility than early-life physical activity (that is, mid-life to later-life activity [139] [140] [141] and occupational physical activity 139, 142 ), raising the possibility that with better measurement early-life physical activity might also protect against prostate cancer to some degree 139 . The inclusion of better estimates of early-life physical activity into overall lifetime measures might also provide a clearer picture of the role of physical activity in prostate carcinogenesis.
Diet.
On the basis of the results of both migration studies and ecological comparisons of national food consumption data with prostate cancer mortality, the diet and, more specifically, a Western diet, is strongly believed to contribute to prostate cancer risk 3 . Despite this strong belief, however, remarkably few studies (n = 7) have examined early-life diet in relation to prostate cancer, especially compared with the extensive literature on mid-life to later-life diet (over several hundred analyses). Moreover, of the few early-life studies that have been conducted, several relied on recall of diet 4-6 decades earlier in life 12, [143] [144] [145] , which is considerably less accurate than recall over fewer decades 146 ; few studies examined nutrients or foods suspected to be associated with prostate cancer risk (FIG. 5) ; few studies examined or published the results of more than one nutrient or aspect of the diet 55, 143, 147, 148 ; and only up to three independent studies investigated the same food or nutrient (the most frequently studied being fat 12, 143 and total dairy or milk intake 12, 55, 144 [149] [150] [151] [152] [153] [154] [155] . Therefore, although findings from many of these studies were null or conflicting, the literature is clearly currently too small and varied to draw sound conclusions about early-life diet. However, given the strong rationale for studying diet and prostate cancer, and the strong potential for primary prostate cancer prevention, more research on early-life diet is clearly needed.
Perspectives
In summary, despite compelling reasons for studying early-life risk factors for prostate cancer, much of the extensive prostate cancer epidemiological literature has focused on mid-life to later-life exposures with few, if any, conclusive, modifiable risk factors identified to date. By contrast, relatively few studies have examined exposures earlier in life, and of these studies many were limited by low exposure recall accuracy (for example, studies of the timing of puberty, as well as early-life physical activity and diet). However, promising findings for other early-life exposures or markers of these exposures that have been examined in a greater number of studies and/or with greater accuracy (that is, migration status, height, early-adulthood body size and early-life sexual activity) provide support for an early-life aetiology for prostate cancer. With better measurement, additional insight into early-life mechanisms of carcinogenesis and opportunities for prostate cancer prevention might be uncovered.
Given these promising observations, and despite the lingering difficulties of studying early-life exposures for such a late-onset cancer, how can the field move forwards? Although one obvious and definitive option would be to carry out cohort studies of males followed from childhood to prostate cancer diagnosis or death, the large expense and time necessary to conduct these studies will limit their number. Therefore, we propose several alternative near-term and longer-term strategies (FIG. 6) .
Near-term strategies. One immediate or near-term strategy is to analyse data from continually maturing cohort studies of children, adolescents or young adults assembled several decades ago, or to link cross-sectional or cohort data collected decades ago with cancer or death registries (for example, Boyd Orr cohort 55 125 and Glasgow Alumni 54 studies). These resources are, however, finite and tend to have smaller sample sizes than are necessary to study prostate cancer as an outcome. Therefore, combined analyses across many of these studies may be required for adequate power. Another near-term option is to reduce the length of recall from old age to at least middle age in epidemiological studies of early-life risk factors, as the accuracy of recall typically improves with reduced recall time 103, 141, 146 . For example, rather than conducting case-control studies of all newly diagnosed eligible prostate cancer cases (for whom the median age at diagnosis in the United States is 67 years 38 ), casecontrol studies including only cases below Figure 6 | Future directions for early-life aetiological studies of prostate cancer. a | One immediate or near-term strategy is to analyse data from continually maturing cohort studies of children, adolescents or young adults assembled several decades ago or to link cross-sectional or cohort data collected several decades ago with cancer or death registries. Another near-term option is to reduce the length of recall from old age to at least middle age in epidemiological studies of early-life risk factors, as the accuracy of recall typically improves with reduced recall time. b | Rather than conducting case-control studies of all newly diagnosed eligible prostate cancer cases, case-control studies that include only cases below a certain age (for example, 55 years of age) could be carried out to increase the accuracy of recall of early-life exposures. c | Cohort analyses that are restricted to younger men at exposure assessment could also be carried out in existing cohort studies. d | As a longer-term strategy, intermediate or surrogate markers of future prostate cancer risk should be studied so that wellcharacterized young boys or men would only need to be followed for the development of intermediate or surrogate markers of risk rather than for the development of prostate cancer. e | In addition to human studies, animal models can also be used to study early-life aetiologies of prostate cancer. For example, early post-neonatal or pubertal exposures could be compared with adult exposures in appropriate animal models. a certain age (for example, 55 years) could be carried out to increase the accuracy of recall of early-life exposures. The restriction of cohort ana lyses to younger men at exposure assessment could also be carried out in existing cohort studies to improve recall accuracy.
These near-term strategies apply both to modifiable exposures, such as the diet, and to markers of early-life sex hormone levels and timing of puberty for their insight into the timing and mechanisms of prostate cancer development. However, another mostly untapped potential source of insight into these aspects of prostate cancer development is germline genetic variation. Although this variation is present from birth, examination of the timing of expression of genes in which prostate cancer-related SNPs and mutations have been found might point to time periods of increased relevance for prostate carcinogenesis. For example, if a particular candidate gene is only expressed early or later in life in the prostate, this finding might suggest the importance of that particular time period for prostate carcinogenesis because the variant or mutated gene product would only function at that time. This information would also be useful for informing when environmental and lifestyle exposures should be assessed in studies of gene-environment interactions.
Finally, in addition to human studies, animal models may also provide insight into early-life aetiologies of prostate cancer. Although applicability to humans is always a consideration, animal studies are advantageous because of their experimental design and shorter time frame to completion compared with human cohort studies. To our knowledge, only a few such animal studies have so far been conducted. However, findings from these studies have been promising, with a greater observed influence of pubertal exposures (for example, testosterone administration and dietary restriction) than adult exposures on prostate cancer-related outcomes [158] [159] [160] . These initial promising findings clearly warrant further animal model research.
Long-term strategies. Most of the nearterm strategies described above can be implemented with existing resources or methodologies. However, new methodologies that reduce the length of time required to study early-life risk factors for prostate cancer should also be developed. For example, intermediate or surrogate markers of future prostate cancer risk should be studied so that well-characterized young boys or men would only need to be followed for a fairly short time period for the development of intermediate or surrogate markers of risk rather than for decades for the development of prostate cancer. This strategy has been used successfully for breast cancer by using benign breast disease as a marker of future breast cancer risk 161 . Additionally, irrespective of their possible use as intermediate or surrogate markers of prostate cancer, early-life histological prostate cancer lesions should also be further investigated for their relevance to later clinically manifest disease and for potential insight into oncogenic mechanisms.
A final consideration for future studies of early-life prostate cancer aetiology is the focus of exposures that are investigated. Although much can be learned about the timing and underlying biological mechanisms of prostate cancer from studies of non-modifiable factors, such as sex hormone levels and timing of puberty, the usefulness of these factors for prostate cancer prevention is mostly limited to possible chemoprevention strategies. Conversely, studies of modifiable factors, such as diet, physical activity and sexual activity or sexually transmissible infections, have the potential to lead to readily implementable and less expensive primary prostate cancer prevention strategies (for example, dietary modification, greater physical activity and vaccination) if they are found to be associated with prostate cancer risk. In particular, greater emphasis should be placed on the diet in future studies, as it is strongly suspected to influence prostate cancer risk but has not yet been examined in any great detail in the early-life epidemiological studies that have been conducted.
None of the strategies outlined above is simple. However, given the high morbidity and mortality of prostate cancer, particularly in Western countries, the current dearth of identified modifiable risk factors to date and the decades of epidemiological research on mid-life to later-life exposures, expanding the research focus to early-life exposures may hold the key to uncovering the aetiology of prostate cancer and pathways for prevention.
